Seeking Alpha

Teva Pharma (TEVA): Q4 EPS of $1.32 misses by $0.01. Revenue of $5.2B misses by $0.06B. (PR)

Teva Pharma (TEVA): Q4 EPS of $1.32 misses by $0.01. Revenue of $5.2B misses by $0.06B. (PR)
Comments (1)
  • To all the "buy Teva, it's dirt cheap..." crowd that appears here regularly: IT JUST GOT CHEAPER!!!!
    7 Feb 2013, 09:48 AM Reply Like
DJIA (DIA) S&P 500 (SPY)